Intuitive Surgical, Inc. Stock

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
375 USD -0.53% Intraday chart for Intuitive Surgical, Inc. +0.22% +11.16%
Sales 2024 * 8.03B Sales 2025 * 9.3B Capitalization 133B
Net income 2024 * 1.96B Net income 2025 * 2.26B EV / Sales 2024 * 15.9 x
Net cash position 2024 * 5.19B Net cash position 2025 * 7.99B EV / Sales 2025 * 13.4 x
P/E ratio 2024 *
69.8 x
P/E ratio 2025 *
60.2 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.53%
1 week+0.22%
Current month-6.03%
1 month-4.84%
3 months+1.33%
6 months+35.19%
Current year+11.16%
More quotes
1 week
364.17
Extreme 364.17
388.65
1 month
364.17
Extreme 364.17
403.76
Current year
320.26
Extreme 320.26
403.76
1 year
254.85
Extreme 254.85
403.76
3 years
180.07
Extreme 180.07
403.76
5 years
120.17
Extreme 120.1667
403.76
10 years
38.50
Extreme 38.4956
403.76
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
President 56 96-02-29
Director of Finance/CFO 52 13-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-03-31
Director/Board Member 69 18-07-30
Director/Board Member 66 07-10-18
More insiders
Date Price Change Volume
24-04-24 375 -0.55% 1,325,633
24-04-23 377.1 +2.21% 1,858,757
24-04-22 368.9 +0.71% 1,603,144
24-04-19 366.3 -1.69% 3,975,892
24-04-18 372.6 -0.41% 2,320,460

Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
375 USD
Average target price
420 USD
Spread / Average Target
+11.98%
Consensus